Interesting article on the differences between European countries and the access to the latest oncology drugs for advanced disease patients. Apparently, the study found that of six western European countries, France had the highest use of oncology drugs, followed respectively by Spain, Germany, Italy, Sweden and the UK.
http://www.pharmatimes.com/Article/13-03-08/New_report_finds_postcode_lottery_for_prostate_cancer.aspx